Equities Analysts Issue Forecasts for Oak Street Health, Inc.’s FY2022 Earnings (NYSE:OSH)

Oak Street Health, Inc. (NYSE:OSHGet Rating) – Stock analysts at William Blair raised their FY2022 earnings estimates for shares of Oak Street Health in a research note issued to investors on Monday, November 7th. William Blair analyst R. Daniels now expects that the company will earn ($2.25) per share for the year, up from their prior forecast of ($2.36). The consensus estimate for Oak Street Health’s current full-year earnings is ($2.44) per share. William Blair also issued estimates for Oak Street Health’s Q4 2022 earnings at ($0.63) EPS, Q1 2023 earnings at ($0.44) EPS, Q2 2023 earnings at ($0.46) EPS, Q3 2023 earnings at ($0.49) EPS, Q4 2023 earnings at ($0.56) EPS and FY2023 earnings at ($1.94) EPS.

Other equities research analysts have also recently issued research reports about the stock. Evercore ISI upped their price objective on shares of Oak Street Health to $37.00 in a research note on Tuesday, August 9th. Canaccord Genuity Group cut their price objective on shares of Oak Street Health from $32.00 to $27.00 in a research note on Wednesday. UBS Group upped their price objective on shares of Oak Street Health from $26.00 to $28.00 and gave the company a “neutral” rating in a research note on Wednesday, August 3rd. Cowen upped their price objective on shares of Oak Street Health to $34.00 in a research note on Tuesday, August 9th. Finally, Barclays increased their price target on shares of Oak Street Health from $31.00 to $34.00 and gave the company an “overweight” rating in a research report on Monday, August 8th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $30.87.

Oak Street Health Stock Performance

Shares of Oak Street Health stock opened at $21.61 on Thursday. Oak Street Health has a 52-week low of $13.29 and a 52-week high of $40.63. The stock has a market capitalization of $5.25 billion, a price-to-earnings ratio of -9.52 and a beta of 2.32. The company has a fifty day moving average of $23.21 and a 200-day moving average of $22.24.

Insider Transactions at Oak Street Health

In other news, COO Brian Clem sold 5,000 shares of the firm’s stock in a transaction dated Tuesday, November 1st. The shares were sold at an average price of $20.57, for a total value of $102,850.00. Following the completion of the sale, the chief operating officer now directly owns 556,337 shares of the company’s stock, valued at approximately $11,443,852.09. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In related news, Director Newlight Partners Lp sold 7,000,000 shares of the stock in a transaction dated Friday, August 19th. The shares were sold at an average price of $24.72, for a total value of $173,040,000.00. Following the completion of the transaction, the director now directly owns 33,509,640 shares in the company, valued at approximately $828,358,300.80. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO Brian Clem sold 5,000 shares of the stock in a transaction dated Tuesday, November 1st. The stock was sold at an average price of $20.57, for a total transaction of $102,850.00. Following the completion of the transaction, the chief operating officer now owns 556,337 shares of the company’s stock, valued at $11,443,852.09. The disclosure for this sale can be found here. In the last ninety days, insiders sold 8,048,496 shares of company stock valued at $199,409,771. Company insiders own 11.40% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of OSH. Capital Research Global Investors increased its stake in shares of Oak Street Health by 61.0% in the 1st quarter. Capital Research Global Investors now owns 11,852,080 shares of the company’s stock worth $318,584,000 after acquiring an additional 4,491,941 shares in the last quarter. Route One Investment Company L.P. increased its stake in Oak Street Health by 92.9% during the 1st quarter. Route One Investment Company L.P. now owns 5,725,037 shares of the company’s stock valued at $153,889,000 after purchasing an additional 2,756,500 shares in the last quarter. Eminence Capital LP bought a new stake in Oak Street Health during the 1st quarter valued at about $73,233,000. MFN Partners Management LP increased its stake in Oak Street Health by 259.3% during the 2nd quarter. MFN Partners Management LP now owns 2,335,329 shares of the company’s stock valued at $38,393,000 after purchasing an additional 1,685,329 shares in the last quarter. Finally, General Equity Holdings LP bought a new stake in Oak Street Health during the 1st quarter valued at about $11,483,000. 91.33% of the stock is currently owned by institutional investors.

Oak Street Health Company Profile

(Get Rating)

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.

See Also

Earnings History and Estimates for Oak Street Health (NYSE:OSH)

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.